eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Symptom | |macular edema |
| Sentences | 187 |
| PubMedID- 21598607 | Medium-term effects of intravitreal bevacizumab for macular edema associated with central retinal vein occlusion. |
| PubMedID- 25576994 | Therapies for macular edema associated with central retinal vein occlusion: a report by the american academy of ophthalmology. |
| PubMedID- 26133058 | Purpose: to evaluate the efficacy and safety of dexamethasone (dex) intravitreal implant for the treatment of macular edema due to branch retinal vein occlusion. |
| PubMedID- 23046435 | Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion. |
| PubMedID- 22876931 | Background: the influence of serous retinal detachment (srd) on visual acuity, macular sensitivity, and macular thickness is unclear after intravitreal injection of triamcinolone acetonide (ivta) for macular edema with branch retinal vein occlusion (brvo). |
| PubMedID- 21734622 | Measurement of retinal sensitivity may be useful for assessing branch retinal vein occlusion patients with macular edema. |
| PubMedID- 24847256 | We report a 19-year-old patient who developed a central retinal vein occlusion (crvo) with significant macular edema and visual impairment following intense exercise and dehydration. |
| PubMedID- 22069354 | Further, the ozurdex geneva study group investigated the efficacy of a dexamethasone intravitreal implant, ozurdex®, for the treatment of macular edema due to retinal vein occlusions. |
| PubMedID- 24634869 | Aim: to compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (rvo). |
| PubMedID- 22668313 | Purpose: to investigate the visual and anatomical effects of intravitreal bevacizumab treatment of macular edema due to central retinal vein occlusion (crvo). |
| PubMedID- 25336905 | Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study. |
| PubMedID- 25960733 | The patient developed acute severe abdominal pain and nausea the day after ivb for retinal vein occlusion with macular edema, and massive lower gastrointestinal bleeding occurred. |
| PubMedID- 22105941 | To investigate whether vitreous fluid levels of vascular endothelial growth factor (vegf), pigment epithelium-derived factor (pedf), and soluble intercellular adhesion molecule 1 (sicam-1) influence visual prognosis and macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 26454243 | Microvascular abnormalities on optical coherence tomography angiography in macular edema associated with branch retinal vein occlusion. |
| PubMedID- 26337664 | Two or more dexamethasone intravitreal implants in treatment-naive patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. |
| PubMedID- 21845030 | Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion. |
| PubMedID- 24191132 | It was also demonstrated to be effective in improving chronic cystoid macular edema (cme) due to retinal vein occlusion . |
| PubMedID- 24068204 | The mechanisms responsible for macular edema with branch retinal vein occlusion (brvo) remain to be elucidated. |
| PubMedID- 20417567 | Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. |
| PubMedID- 26431300 | Bevacizumab versus ranibizumab in the treatment of macular edema due to retinal vein occlusion: 6-month results of the crave study. |
| PubMedID- 25748280 | Purpose: to compare the risks and benefits of adding either intravitreal dexamethasone implant (dex) or preservative-free triamcinolone acetonide (ta) to bevacizumab monotherapy in refractory cystoid macular edema due to retinal vein occlusion. |
| PubMedID- 23650454 | The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions. |
| PubMedID- 23629790 | Background: the efficacy of a single dose of ozurdex(r) was evaluated over a 6-month period in eyes with macular edema due to retinal vein occlusion and intraocular inflammatory disease. |
| PubMedID- 25390716 | Conclusion: ozurdex may be effective in reducing macular edema because of a branch retinal vein occlusion in eyes refractory to multiple other treatments. |
| PubMedID- 26117932 | The paper presents the first results concerning the aflibercept (eylea) treatment, the last antivegf approved for treatment of the age related macular degeneration (amd), neovascular form and for macular edema due to the central retinal vein occlusion. |
| PubMedID- 24526927 | The ozurdex dexamethasone-sustained delivery implant has been approved by the united states food and drug administration (fda) for the treatment of macular edema associated with retinal vein occlusion (rvo) and for noninfectious posterior uveitis. |
| PubMedID- 22358585 | Purpose: to evaluate the visual outcomes of three different treatments for macular edema associated with a branch retinal vein occlusion. |
| PubMedID- 20858114 | Conclusion: intravitreal injection of triamcinolone, bevacizumab or combination of triamcinolone-bevacizumab appears to have similar therapeutic effects on macular edema due to branch retinal vein occlusion at one month. |
| PubMedID- 22481482 | Methods: forty-seven consecutive eyes from 47 patients with macular edema associated with branch retinal vein occlusion treated with intravitreal bevacizumab injection were retrospectively reviewed. |
| PubMedID- 25644536 | Purpose: to determine whether the highly reflective vertical lines seen in spectral-domain optical coherence tomographic (sd oct) images, which we have termed track lines, after resolution of macular edema associated with branch retinal vein occlusion are related to the integrity of the photoreceptors. |
| PubMedID- 24439442 | Purpose: to determine whether a significant correlation exists between the presence of a bulge in the photoreceptor inner segment/outer segment (is/os) line and the best-corrected visual acuity (bcva) in eyes with resolved macular edema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 22653545 | Purpose: to evaluate the changes of macular sensitivity, thickness, and total macular volume after intravitreal injection of triamcinolone acetonide to treat macular edema with branch retinal vein occlusion. |
| PubMedID- 21386915 | In agreement with this hypothesis, we previously found that the vitreous level of vegf was lower at the time of repeat vitrectomy than at the initial operation in patients with macular edema due to retinal vein occlusion,33 and it was also reported that ppv prevents retinal hypoxia in patients with brvo.34 we recently demonstrated that the vitreous fluid level of pedf has a significant negative correlation with the nonperfused area of the retina.3 accordingly, expression of pedf may be upregulated to prevent retinal hypoxia after ppv, and this may be another mechanism by which ppv improves macular edema in brvo patients. |
| PubMedID- 25896233 | Aims: to evaluate changes in macular morphology and function after repeated intravitreal dexamethasone implant (ozurdex(r)) for macular edema (me) due to retinal vein occlusion (rvo). |
| PubMedID- 24531560 | Association of electroretinogram and morphological findings in central retinal vein occlusion with macular edema. |
| PubMedID- 20681253 | Pathogenesis of macular edema associated with branch retinal vein occlusion and strategy for treatment. |
| PubMedID- 21784203 | Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. |
| PubMedID- 22824616 | Clinical findings and investigations confirmed nonischemic central retinal vein occlusion (crvo) with persisting macular edema. |
| PubMedID- 23984139 | Dexamethasone implant (ozurdex) is approved for eyes with posterior uveitis and macular edema associated with retinal vein occlusions . |
| PubMedID- 20432959 | Purpose: to examine the short-term effects of intravitreal injections of bevacizumab on macular edema due to central retinal vein occlusion (crvo). |
| PubMedID- 20827142 | Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. |
| PubMedID- 26395854 | macular edema due to retinal vein occlusion is the second most common cause of vascular vision impairment. |
| PubMedID- 22824618 | A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. |
| PubMedID- 25902116 | Patients and methods: a case series of treatment naive patients followed in the jules gonin eye hospital for macular edema due to central retinal vein occlusion is presented. |
| PubMedID- 20148661 | Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion. |
| PubMedID- 25705695 | To compare the efficacy of different therapies in the treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 20453544 | The outcome of vitrectomy for macular edema was examined in patients with central retinal vein occlusion (crvo), as well as whether vascular endothelial growth factor (vegf) and interleukin-6 (il-6) levels in vitreous fluid influence the visual prognosis and macular edema. |
| PubMedID- 26418442 | Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion. |
| PubMedID- 23255086 | Purpose: to evaluate the functional and structural changes of extrafoveal macula after intravitreal bevacizumab (ivb) injection in patients with macular edema due to branch retinal vein occlusion (brvo) using multifocal electroretinogram (mferg) and optical coherence tomography (oct). |
| PubMedID- 22925843 | Purpose: to evaluate the efficacy of bevacizumab injection used secondarily in patients with macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide injection. |